Unveiling the Future of Radiology: Key Trends from RSNA 2023
At RSNA, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience.
At RSNA, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience.
At RSNA 2023, AI startup Hoppr announced that it teamed up with AWS to launch a new foundation model. The product, named Grace, is a B2B model designed to help application developers build better AI solutions for the medical imaging field — and to build them more quickly.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Many of the efforts to address healthcare's burnout crisis have centered on money, such as hiring and retention bonuses, but that isn’t sustainable. Providers don’t have the means to keep throwing money at the problem forever, so they should focus more on creating a workplace culture where employees feel valued and supported.
The South Florida group is applying Watson-powered "cognitive peer review" to medical imaging in an effort to diagnose aortic stenosis earlier.
McKesson discussed Conserus at last week's RSNA conference in Chicago.
At the annual meeting of the Radiological Society of North America, experts discussed whether computer-aided diagnosis is a powerful tool for radiologists or a way to make them obsolete.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
At the annual Radiological Society of North America in Chicago, speakers in several sessions called for a full embrace of value-based care despite the uncertainty wrought by the elections.
Like many new entrants to this vast industry, IBM Watson Health is still trying to figure things out, but the nascent division of Big Blue does have a decided advantage over the average startup.
Also, Roche backs out of a superbug project, a look at text messaging in mental health, and a new Takeda-Teva partnership.